Pune (Maharashtra): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
As per the official statement of the Sassoon General Hospital, volunteer registration is currently going on for the trials.
"Phase III of Covishield Vaccine trial has been started in Sassoon General Hospital, Pune. At present, volunteer registration is going on for this. Those who are willing to volunteer for vaccination can contact on the following numbers--8550960196, 8104201267," said the statement.
On September 16, it was reported that the Drugs Controller General of India (DCGI) has allowed the Serum Institute of India to restart its phase two and three clinical trials for the Covishield Vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSMB), UK and DSMB India and requested permission to restart enrolment in the subject clinical trial of the vaccine.
Read: DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19 vaccine
AstraZeneca had earlier paused the ongoing trial of nCoV19 coronavirus vaccine (recombinant) as a volunteer developed an unexplained illness.
It was reported that the clinical trial had been put on hold in the US, UK, Brazil and South Africa.
Following this, the country's top drugs regulator had September 11 ordered the SII to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
(ANI Report)
